Differential patterns of effects of age and sex on metabolic syndrome in Taiwan: Implication for the inadequate internal consistency of the current criteria

Diabetes Research and Clinical Practice

Volumn 105, Issue 2, 2014, Pages 239-244

  Wu, Tzu Wei ^a   Chan, Hsin Lung ^b   Hung, Chung Lieh ^b   Lu, I Jung ^c   Wang, Shwun De ^a   Wang, Shih Wei ^a   Wu, Yih Jer ^a,b   Wang, Li Yu ^a   Yeh, Hung I ^a,b   Wei, Yau Huei ^a  

^a MACKAY MEDICAL COLLEGE   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c CHIHLEE INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

Age; Internal consistency; Metabolic syndrome; Population based analysis; Sex; Surveys

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CRONBACH ALPHA COEFFICIENT; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INTERNAL CONSISTENCY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; REFERENCE VALUE; SEASHORE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL; VERY ELDERLY; WAIST CIRCUMFERENCE;

AGE; INTERNAL CONSISTENCY; METABOLIC SYNDROME; POPULATION-BASED ANALYSIS; SEX; SURVEYS;

ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; SEX FACTORS; TAIWAN;

EID: 84906047502     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.04.027     Document Type: Article

References (41)

1. Haffner S.M., Valdez R.A., Hazuda H.P., Mitchell B.D., Morales P.A., Stern M.P. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992, 41(6):715-722.
2. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
3. Dekker J.M., Girman C., Rhodes T., Nijpels G., Stehouwer C.D., Bouter L.M., et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005, 112:666-673.
4. McNeill A.M., Rosamond W.D., Girman C.J., Golden S.H., Schmidt M.I., East H.E., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005, 28:385-390.
5. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005, 112:3066-3072.
6. Kurl S., Laukkanen J.A., Niskanen L., Laaksonen D., Sivenius J., Nyyssonen K., et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006, 37:806-811.
7. International Diabetes Federation (IDF) The IDF consensus worldwide definition of the metabolic syndrome [accessed 12.11.12]. http://www.idf.org/metabolic-syndrome.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
9. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
10. Chien K.L., Hsu H.C., Sung F.C., Su T.C., Chen M.F., Lee Y.T. Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis 2007, 194:214-221.
11. Dhaliwal S.S., Welborn T.A. Central obesity and cigarette smoking are key determinants of cardiovascular disease deaths in Australia: a public health perspective. Prev Med 2009, 49:153-157.
12. Fox K.A., Despres J.P., Richard A.J., Brette S., Deanfield J.E., IDEA Steering Committee and National Co-ordinators Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries. Eur Heart J 2009, 30:3055-3063.
13. Hozawa A., Kuriyama S., Kakizaki M., Ohmori-Matsuda K., Ohkubo T., Tsuji I. Attributable risk fraction of prehypertension on cardiovascular disease mortality in the Japanese population: the Ohsaki Study. Am J Hypertens 2009, 22:267-272.
14. Grau M., Subirana I., Elosua R., Fito M., Covas M.I., Sala J., et al. Why should population attributable fractions be periodically recalculated? An example from cardiovascular risk estimation in southern Europe. Prev Med 2010, 51:78-84. REGICOR Investigators.
15. Wu S.H., Liu Z., Ho S.C. Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. Eur J Epidemiol 2010, 25:375-384.
16. Ford E.S. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004, 173(2):309-314.
17. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005, 28:2745-2749.
18. Hildrum B., Mykletun A., Dahl A.A., Midthjell K. Metabolic syndrome and risk of mortality in middle-aged versus elderly individuals: the Nord-Trondelag Health Study (HUNT). Diabetologia 2009, 52:583-590.
19. Lin J.W., Caffrey J.L., Chang M.H., Lin Y.S. Sex, menopause, metabolic syndrome, and all-cause and cause-specific mortality - cohort analysis from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2010, 95:4258-4267.
20. Shaposhnikov M.V. Life span sexual dimorphism. Adv Gerontol 2008, 21:507-509.
21. Muller M., Grobbee D.E., den Tonkelaar I., Lamberts S.W., van der Schouw Y.T. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 2005, 90:2618-2623.
22. Yeap B.B. Testosterone and ill-health in aging men. Nat Clin Pract Endocrinol Metab 2009, 5:113-121.
23. Arnlov J., Pencina M.J., Amin S., Nam B.H., Benjamin E.J., Murabito J.M., et al. Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med 2006, 145:176-184.
24. Luczak E.D., Leinwand L.A. Sex-based cardiac physiology. Annu Rev Physiol 2009, 71:1-18.
25. Bhupathy P., Haines C.D., Leinwand L.A. Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health (Lond Engl) 2010, 6:77-95.
26. Yeh C.J., Chang H.Y., Pan W.H. Time trend of obesity, the metabolic syndrome and related dietary pattern in Taiwan: from NAHSIT 1993-1996 to NAHSIT 2005-2008. Asia Pac J Clin Nutr 2011, 20:292-300.
27. Lin C.P., Lin Y.S., Wu S.C., Ko Y.S. Age- and gender-specific association between intraocular pressure and metabolic variables in a Taiwanese population. Eur J Intern Med 2012, 23:76-82.
28. Wang W.S., Wahlqvist M.L., Hsu C.C., Chang H.Y., Chang W.C., Chen C.C. Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan. BMC Public Health 2012, 12:111.
29. Mozaffarian D., Kamineni A., Prineas R.J., Siscovick D.S. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 2008, 168:969-978.
30. Hung C.L., Wu Y.J. Rationale and Design of MAGNET (Mitochondria-AGing in NorthErn Taiwan) Study: a community-based cohort investigating mitochondria-related aging and cardiovascular diseases in suburban areas of Northern Taiwan. Int J Gerontol 2012, 6:122-126.
31. Cortina J.M. What is coefficient alpha? An example of theory and applications. J Appl Psychol 1993, 78:98-104.
32. McDowell I. The theoretical and technical foundations of health management. Measuring health: a guide to rating scales and questionnaire 2006, 10-54. Oxford University Press, New York. 3rd ed.
33. Kline P. The handbook of psychological testing 2000, Routledge, London. 2nd ed.
34. Bo M., Sona A., Astengo M., Fiandra U., Quagliotti E., Brescianini A., et al. Metabolic syndrome in older subjects: coincidence or clustering?. Arch Gerontol Geriatr 2009, 48:146-150.
35. Hwang L.C., Bai C.H., Chen C.J., Chien K.L. Gender difference on the development of metabolic syndrome: a population-based study in Taiwan. Eur J Epidemiol 2007, 22:899-906.
36. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003, 163:427-436.
37. Urashima M., Wada T., Fukumoto T., Joki M., Maeda T., Hashimoto H., et al. Prevalence of metabolic syndrome in a 22892 Japanese population and its association with life style. JMAJ 2005, 48:441-450.
38. Kaykhaei M., Hashemi M., Narouie B., Shikhzadeh A., Jahantigh M., Shirzaei E., et al. Prevalence of metabolic syndrome in adult population from Zahedan, southeast Iran. Iran J Public Health 2012, 41:70-76.
39. Gyakobo M., Amoah A.G., Martey-Marbell D.A., Snow R.C. Prevalence of the metabolic syndrome in a rural population in Ghana. BMC Endocr Disord 2012, 12:25.
40. Rampal S., Mahadeva S., Guallar E., Bulgiba A., Mohamed R., Rahmat R., et al. Ethnic differences in the prevalence of metabolic syndrome: results from a multi-ethnic population-based survey in Malaysia. PLoS ONE 2012, 7:e46365.
41. Prasad D.S., Kabir Z., Dash A.K., Das B.C. Prevalence and risk factors for metabolic syndrome in Asian Indians: a community study from urban Eastern India. J Cardiovasc Dis Res 2012, 3:204-211.